Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating Sickle Cell Disease
Phase 1 / Phase 2 · 1 site
Search the registry
2,585 studies found
Phase 1 / Phase 2 · 1 site
Phase 2 · 1 site
Phase 2 · 1 site
Potential match only. Final eligibility is determined by the study team.